UK markets open in 58 minutes

UroGen Pharma Ltd. (URGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.78-0.19 (-1.12%)
At close: 04:00PM EDT
16.78 0.00 (0.00%)
After hours: 04:24PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
95,002
55,408
44,360
52,864
-
Other short-term investments
41,966
44,556
44,779
49,154
-
Total cash
136,968
99,964
89,139
102,018
-
Net receivables
15,443
12,704
11,717
7,047
-
Inventory
5,673
4,325
4,832
1,964
-
Other current assets
10,281
11,101
7,476
3,364
-
Total current assets
169,186
128,907
114,390
115,619
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,312
6,899
5,373
5,599
-
Accumulated depreciation
-3,952
-3,150
-2,226
-1,395
-
Net property, plant and equipment
2,360
3,749
3,147
4,204
-
Equity and other investments
4,502
0
675
1,893
-
Other long-term assets
2,263
2,963
1,534
289
-
Total non-current assets
9,125
6,712
5,356
6,386
-
Total assets
178,311
135,619
119,746
122,005
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,514
5,527
5,786
3,271
-
Accrued liabilities
10,024
6,856
6,316
6,752
-
Other current liabilities
3,860
3,276
3,330
1,859
-
Total current liabilities
31,212
23,916
22,380
21,436
-
Non-current liabilities
Long-term debt
98,551
97,537
-
-
-
Deferred tax liabilities
-
3,018
2,842
2,717
0
Other long-term liabilities
-
98,923
85,713
2,717
-
Total non-current liabilities
212,311
201,064
88,953
4,214
-
Total liabilities
243,523
224,980
111,333
25,650
-
Stockholders' equity
Common stock
89
63
61
60
-
Retained earnings
-679,348
-577,104
-467,321
-356,501
-
Accumulated other comprehensive income
12
-107
-25
271
-
Total stockholders' equity
-65,212
-89,361
8,413
96,355
-
Total liabilities and stockholders' equity
178,311
135,619
119,746
122,005
-